Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1995-2002
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1995
Table 1 Comparison of clinicopathological features between the recurrence group and non-recurrence group, n (%)
Groups
Recurrence group (n = 69)
Non-recurrence group (n = 41)
t value
P value
Age (mean ± SD, yr) 54.63 ± 15.5855.10 ± 15.29
Gender3.4970.061
    Men40 (57.97)31 (75.61)
    Female29 (42.03)10 (24.39)
HbsAg0.3130.576
    Negative22 (31.88)11 (26.83)
    Positive47 (68.12)30 (73.17)
TNM staging10.9590.001
    Stage I-II28 (40.58)30 (73.17)
    Stage III-IV41 (59.42)11 (26.83)
Tumor diameter0.9790.323
    < 5 cm 27 (39.13)20 (48.78)
    ≥ 5 cm 42 (60.87)21 (51.22)
Degree of tumor differentiation6.3530.012
    Low differentiation 30 (43.48)28 (68.29)
    High differentiation 39 (56.52)13 (31.71)
Lymph node metastasis5.2080.022
    Yes30 (43.48)9 (21.95)
    No39 (56.52)32 (78.05)
Number of tumors0.2980.585
    Multiple44 (63.77)24 (58.54)
    Single25 (36.23)17 (41.46)
Alpha-fetoprotein (μg/L)3.1370.077
    < 20037 (53.62)29 (70.73)
    ≥ 20032 (46.38)12 (29.27)